Recent Antiphospholipid Syndrome News:

 

• Timing of initiation of low-molecular-weight heparin administration in pregnant women with …
• Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated …
• Ocular Therapeutix, Inc. (OCUL) Is At $4.31 Formed Wedge; Select Medical Holdings Has 0.91 …
• DAPT Effective, Safe for Prophylaxis of Arterial Thrombosis in Antiphospholipid Syndrome
• Ocular Therapeutix, Inc. (OCUL) Is At $4.13 Formed Wedge; Van Den Berg Management I Trimmed …
• Ocular Therapeutix, Inc. (OCUL) Is At $4.16 Formed Wedge; BESPOKE EXTRACTS (BSPK) Shorts …
• Study Supports Antibody Testing in Obstetrical Lupus Treatment
• Miriam Quiambao pregnancy threatened with autoimmune disease
• Miriam Quiambao opens up about autoimmune disorder during pregnancy
• Miriam Quiambao diagnosed with autoimmune disorder risky for pregnant women
• Fat-targeting Autoantibodies Linked to Increased Risk of Blood Clots, Miscarriage in Scleroderma …
• Antiphospholipid syndrome in man with severe pulmonary hypertension
• High Pointe Capital Management Has Lifted Stake in Qualcomm (QCOM); Sv Life Sciences …
• As Ocular Therapeutix (OCUL) Stock Value Declined, Shareholder Sv Life Sciences Advisers …
• Ancora Advisors Has Raised Corvel (CRVL) Holding by $414882; Sv Life Sciences Advisers …
• As Ocular Therapeutix (OCUL) Share Price Declined, Sv Life Sciences Advisers Has Cut Position …
• As Microsoft (Put) (MSFT) Share Value Rose, Arrowgrass Capital Partners LP Has Lowered Its …
• What is Antiphospholipid Syndrome?
• The English Prof. Graham Hughes to Be Awarded the Hamdan Award for Medical Research …
• Xpo Logistics (XPO) Holder Fishman Jay A LTD Has Raised Holding by $62.61 Million; As Ocular …
• Sv Life Sciences Advisers Position in Ocular Therapeutix (OCUL) Decreased by $2.16 Million …
• ‘I don’t want to risk it’: Model Robyn Lawley, 29, reveals the heartbreaking reason she won’t have …
• Koch Industries Has Trimmed Formfactor (FORM) Stake by $531011; Sv Life Sciences Advisers …

Antiphospholipid Syndrome News:

 

• Nine research updates in thrombosis treatment, surveillance and risk prediction.

• Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.

• Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.

• Autoantibodies may be a risk factor for heart attack

• Heart attack: New finding may change the face of treatment

• Hughes syndrome (antiphospholipid syndrome) and the nervous system.

• When autoimmune diseases exert neuro-ophthalmic effects

• Catastrophic antiphospholipid syndrome: The current management approach.

•  2016 review on catastrophic antiphospholipid syndrome.

• Antiphospholipid syndrome in obstetrics.

• Pregnancy and APS: Results Look Encouraging

• The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

• Anticoagulating patients with high-risk acquired thrombophilias.

• Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

• Catastrophic antiphospholipid syndrome: The current management approach.

• Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome.  case report
• C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
• Myasthenia gravis  is sometimes found in conjunction with antiphospholipid syndrome with: A case report
• Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
  
• Good news for prospective mothers with antiphospholipid syndrome? –  Journal of Postgraduate Medicine
• New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases

• Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist

• Antiphospholipid syndrome plus rheumatic fever: A higher risk factor for stroke? – MD Linx

• Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review

• Antiphospholipid syndrome: endocrinologic manifestations and organ involvement